USP in the News

professional examining prescription bottle
Center for Biosimilars
Little-Known Provision of Senate Healthcare Bill Has Some Biosimilar Stakeholders Worried

One provision of the Lower Health Care Costs Act that has garnered significantly less attention from the broader healthcare community has raised concerns among many biologics stakeholders.

researcher studying readings on a screen
Inside Health Policy
Experts: Biologic Product Monographs Do Not Impede On FDA’s Authority

Some biologics experts are perplexed by the Trump administration’s argument that subjecting biologics products to United States Pharmacopeia (USP) monographs would hamper innovation.

Stay Connected
Stay Connected…

Sign up for the latest USP News Releases!